RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of RAPT Therapeutics Inc..
RAPT Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of RAPT Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of RAPT Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of RAPT Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of RAPT Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of RAPT Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 RAPT Therapeutics Inc.- Key Facts
2.2 RAPT Therapeutics Inc.- Geographic Locations
2.3 RAPT Therapeutics Inc.- Subsidiaries and Affiliates
2.4 RAPT Therapeutics Inc.- Business Divisions
2.5 RAPT Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. RAPT Therapeutics Inc. Strategic Analysis Review
3.1 RAPT Therapeutics Inc.- Key Strategies
3.2 RAPT Therapeutics Inc.- Company Outlook Statement
3.3 RAPT Therapeutics Inc.- SWOT Analysis
3.3.1 RAPT Therapeutics Inc.- Key Strengths
3.3.2 RAPT Therapeutics Inc.- Key Weaknesses
3.3.3 RAPT Therapeutics Inc.- Potential Opportunities
3.3.4 RAPT Therapeutics Inc.- Potential Threats
3.4 RAPT Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 RAPT Therapeutics Inc.- Business Overview
4.2 RAPT Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 RAPT Therapeutics Inc.- Key Products
5.2 RAPT Therapeutics Inc.- Key Service Areas
5.3 RAPT Therapeutics Inc.- Key Brands
6 Company Developments
6.1 RAPT Therapeutics Inc.- Company History
6.2 RAPT Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 RAPT Therapeutics Inc.- Income Statements
7.2 RAPT Therapeutics Inc.- Balance Sheet
7.3 RAPT Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 RAPT Therapeutics Inc.- Direct Competitors
8.2 RAPT Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 RAPT Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 RAPT Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!